Literature DB >> 12594452

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.

Mihai Gheorghiade1, Wendy A Gattis, Alejandro Barbagelata, Kirkwood F Adams, Uri Elkayam, Cesare Orlandi, Christopher M O'Connor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12594452     DOI： 10.1067/mhj.2003.154

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  8 in total

1.  Effects of tolvaptan on dyspnoea relief from the EVEREST trials.

Authors:  Peter S Pang; Marvin A Konstam; Holly B Krasa; Karl Swedberg; Faiez Zannad; John E A Blair; Christopher Zimmer; John R Teerlink; Aldo P Maggioni; John C Burnett; Liliana Grinfeld; John Ouyang; James E Udelson; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2009-06-27       Impact factor: 29.983

Review 2.  Role of vasopressin antagonists in the management of acute decompensated heart failure.

Authors:  Cesare Orlandi; Christopher A Zimmer; Mihai Gheorghiade
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 3.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 4.  Significance of hyponatremia in heart failure.

Authors:  Luca Bettari; Mona Fiuzat; Gary M Felker; Christopher M O'Connor
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

5.  Tolvaptan, hyponatremia, and heart failure.

Authors:  Hammam D Zmily; Suleiman Daifallah; Jalal K Ghali
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-03-31

Review 6.  Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.

Authors:  Evi V Nagler; Maria C Haller; Wim Van Biesen; Raymond Vanholder; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28

7.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

Review 8.  Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review.

Authors:  Elke Platz; Pardeep S Jhund; Ross T Campbell; John J McMurray
Journal:  Eur J Heart Fail       Date:  2015-07-31       Impact factor: 15.534
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.